Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04488991
Status:
UNKNOWN
Last Update Posted:
2020-07-28
First Post:
2020-07-16
Brief Title:
Nabothian Cyst Protects or Facilitates Against Cervical Cancer
Sponsor:
Haseki Training and Research Hospital
Organization:
Haseki Training and Research Hospital
Study Overview
Official Title:
Naboth Kisti ve HPV pozitifliği arasındaki ilişkinin araştırılması
Status:
UNKNOWN
Status Verified Date:
2020-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aim of the study to asses the realition between HPV infection Nabothian Cyst and Cervical Intraepithelial lesions or Cervical Cancer
Detailed Description:
Nabothian cysts are one of the common gynecological pathologies They rarely have clinical significance Transvaginal ultrasonography and magnetic resonance imaging are the most useful imaging methods for cervical cystic lesionsHPV infection is the most important factor which can cause cervical malignancy and premalignant lesions In women between 30-65 years of age HPV-DNA testing is used as a screening test in Turkey In this research the aim is to examine whether there is a connection between Naboth cysts and HPV infection in the cervix During the examination the swab sample required for HPV PCR testing will be taken The number and size of Naboth cysts with vaginal USG will be noted If the patient had colposcopy LEEP Loop Electrosurgical Excision Procedure the result will be investigated and noted
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None